Prevalence of vertebral fractures in a disease activity steered cohort of patients with early active rheumatoid arthritis

BMC Musculoskeletal Disorders

Volumn 13, Issue , 2012, Pages

  Dirven, Linda ^a   Van Den Broek, M ^a   Van Groenendael, J H L M ^b   De Beus, W M ^c   Kerstens, P J S M ^d   Huizinga, T W J ^a   Allaart, C F ^a   Lems, W F ^d,e  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Franciscus Hospital   (Netherlands)

^c MCH Haaglanden   (Netherlands)

^d Jan Van Breemen Research Institute/Reade   (Netherlands)

^e VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Bone mineral density; Disease activity; Functional ability; Rheumatoid arthritis; Treatment strategy; Vertebral fractures

Indexed keywords

C REACTIVE PROTEIN; INFLIXIMAB; PREDNISONE;

ADULT; AGE; ARTICLE; BODY HEIGHT; BODY MASS; BONE DENSITY; COHORT ANALYSIS; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DISEASE ACTIVITY; DISEASE DURATION; DRUG MEGADOSE; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FUNCTIONAL DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENOPAUSE; MONOTHERAPY; PREVALENCE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RHEUMATOID ARTHRITIS; SCORING SYSTEM; SEX DIFFERENCE; SMOKING; SPINE FRACTURE; SPINE RADIOGRAPHY; AGED; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CROSS-SECTIONAL STUDY; DISABILITY; INJURY; LUMBAR VERTEBRA; MIDDLE AGED; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; NETHERLANDS; QUESTIONNAIRE; RADIOGRAPHY; RANDOMIZED CONTROLLED TRIAL; RISK; RISK ASSESSMENT; RISK FACTOR; SEVERITY OF ILLNESS INDEX; STATISTICAL MODEL; TIME;

ADULT; AGE FACTORS; AGED; ARTHRITIS, RHEUMATOID; BONE DENSITY; CROSS-SECTIONAL STUDIES; DISABILITY EVALUATION; FEMALE; HUMANS; LINEAR MODELS; LOGISTIC MODELS; LUMBAR VERTEBRAE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NETHERLANDS; ODDS RATIO; PREVALENCE; QUESTIONNAIRES; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SPINAL FRACTURES; TIME FACTORS;

EID: 84868228023     PISSN: None     EISSN: 14712474     Source Type: Journal    
DOI: 10.1186/1471-2474-13-125     Document Type: Article

References (25)

1. Association of bone mineral density and vertebral deformity in patients with rheumatoid arthritis. Baskan BM, Sivas F, Alemdaroglu E, Duran S, Ozoran K, Rheumatol Int 2007 27 579 584 10.1007/s00296-007-0323-8 17287933 (Pubitemid 46411901)
2. Prevalence of vertebral fractures in patients with rheumatoid arthritis: revisiting the role of glucocorticoids. Ghazi M, Kolta S, Briot K, Fechtenbaum J, Paternotte S, Roux C, Osteoporos Int 2011 1 1
3. Vertebral deformities in rheumatoid arthritis: a comparison with population-based controls. Orstavik RE, Haugeberg G, Mowinckel P, Hoiseth A, Uhlig T, Falch JA, et al. Arch Intern Med 2004 164 420 425 10.1001/archinte.164. 4.420 14980993 (Pubitemid 38240706)
4. Risk of vertebral fracture in women with rheumatoid arthritis. Spector TD, Hall GM, McCloskey EV, Kanis JA, BMJ 1993 306 558 10.1136/bmj.306.6877.558 8461772 (Pubitemid 23056878)
5. Clinical assessment of the long-term risk of fracture in patients with rheumatoid arthritis. van Staa TP, Geusens P, Bijlsma JW, Leufkens HG, Cooper C, Arthritis Rheum 2006 54 3104 3112 10.1002/art.22117 17009229 (Pubitemid 44622079)
6. Factors influencing fracture risk, T score, and management of osteoporosis in patients with rheumatoid arthritis in the Consortium of Rheumatology Researchers of North America (CORRONA) registry. Coulson KA, Reed G, Gilliam BE, Kremer JM, Pepmueller PH, J Clin Rheumatol 2009 15 155 160 10.1097/RHU.0b013e3181a5679d 19363452
7. Prevalence and risk factors of vertebral fractures in women with rheumatoid arthritis using vertebral fracture assessment. El Maghraoui A, Rezqi A, Mounach A, Achemlal L, Bezza A, Ghozlani I, Rheumatology (Oxford) 2010 49 1303 1310 10.1093/rheumatology/keq084
8. Association between vertebral fracture and increased mortality in osteoporotic patients. Jalava T, Sarna S, Pylkkanen L, Mawer B, Kanis JA, Selby P, et al. J Bone Miner Res 2003 18 1254 1260 10.1359/jbmr.2003.18.7.1254 12854835 (Pubitemid 37294918)
9. Asymptomatic vertebral deformity as a major risk factor for subsequent fractures and mortality: a long-term prospective study. Pongchaiyakul C, Nguyen ND, Jones G, Center JR, Eisman JA, Nguyen TV, J Bone Miner Res 2005 20 1349 1355 10.1359/JBMR.050317 16007332 (Pubitemid 41033519)
10. Risk factors for vertebral fracture in menopausal or postmenopausal Japanese women with rheumatoid arthritis: a cross-sectional and longitudinal study. Arai K, Hanyu T, Sugitani H, Murai T, Fujisawa J, Nakazono K, et al. J Bone Miner Metab 2006 24 118 124 10.1007/s00774-005-0657-9 16502118
11. Changes in hand and generalised bone mineral density in patients with recent-onset rheumatoid arthritis. Güler-Yüksel M, Allaart CF, Goekoop-Ruiterman YP, de Vries-Bouwstra JK, van Groenendael JH, Mallee C, et al. Ann Rheum Dis 2009 68 330 336 10.1136/ard.2007.086348 18375540
12. Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial. Grigor C, Capell H, Stirling A, McMahon AD, Lock P, Vallance R, et al. Lancet 2004 364 263 269 10.1016/S0140-6736(04)16676-2 15262104 (Pubitemid 38942816)
13. Intensive treatment with methotrexate in early rheumatoid arthritis: aiming for remission. Computer Assisted Management in Early Rheumatoid Arthritis (CAMERA, an open-label strategy trial). Verstappen SM, Jacobs JW, van der Veen MJ, Heurkens AH, Schenk Y, ter Borg EJ, et al. Ann Rheum Dis 2007 66 1443 1449 10.1136/ard.2007.071092 17519278 (Pubitemid 350032650)
14. Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis. Boers M, Verhoeven AC, Markusse HM, van de Laar MA, Westhovens R, van Denderen JC, et al. Lancet 1997 350 309 318 10.1016/S0140-6736(97)01300-7 9251634 (Pubitemid 27351112)
15. The PREMIER study: a multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment. Breedveld FC, Weisman MH, Kavanaugh AF, Cohen SB, Pavelka K, van Vollenhoven VR, et al. Arthritis Rheum 2006 54 26 37 10.1002/art.21519 16385520 (Pubitemid 43122183)
16. Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial. Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Allaart CF, van Zeben D, Kerstens PJ, Hazes JM, et al. Arthritis Rheum 2005 52 3381 3390 10.1002/art.21405 16258899 (Pubitemid 41612204)
17. Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial. Klareskog L, van der Heijde D, de Jager JP, Gough A, Kalden J, Malaise M, et al. Lancet 2004 363 675 681 10.1016/S0140-6736(04)15640-7 15001324 (Pubitemid 38296553)
18. Aiming at low disease activity in rheumatoid arthritis with initial combination therapy or initial monotherapy strategies: the BeSt study. Allaart CF, Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Breedveld FC, Dijkmans BA, Clin Exp Rheumatol 2006 24 82 17083771
19. High incidence of vertebral and non-vertebral fractures in the OSTRA cohort study: a 5-year follow-up study in postmenopausal women with rheumatoid arthritis. Vis M, Haavardsholm EA, Boyesen P, Haugeberg G, Uhlig T, Hoff M, et al. Osteoporos Int 2011 22 2413 2419 10.1007/s00198-010-1517-6 21229234
20. The incidence of vertebral fractures in men and women: the Rotterdam Study. Van der Klift M, De Laet CE, McCloskey EV, Hofman A, Pols HA, J Bone Miner Res 2002 17 1051 1056 10.1359/jbmr.2002.17.6.1051 12054160 (Pubitemid 34535143)
21. Effects of 4-year treatment with once-weekly clodronate on prevention of corticosteroid-induced bone loss and fractures in patients with arthritis: evaluation with dual-energy X-ray absorptiometry and quantitative ultrasound. Frediani B, Falsetti P, Baldi F, Acciai C, Filippou G, Marcolongo R, Bone 2003 33 575 581 10.1016/S8756-3282(03)00208-4 14555261 (Pubitemid 37229075)
22. Changes in bone mineral density in patients with recent onset, active rheumatoid arthritis. Güler-Yüksel M, Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Hulsmans HM, de Beus WM, Han KH, et al. Ann Rheum Dis 2008 67 823 828 10.1136/ard.2007.073817 17644545 (Pubitemid 351829383)
23. Effect of combined risedronate and hormone replacement therapies on bone mineral density in postmenopausal women. Harris ST, Eriksen EF, Davidson M, Ettinger MP, Moffett AHJ Jr, Baylink DJ, et al. J Clin Endocrinol Metab 2001 86 1890 1897 10.1210/jc.86.5.1890 11344179 (Pubitemid 32472892)
24. A multicenter cross sectional study on bone mineral density in rheumatoid arthritis. Italian Study Group on Bone Mass in Rheumatoid Arthritis. Sinigaglia L, Nervetti A, Mela Q, Bianchi G, Del PA, Di MO, et al. J Rheumatol 2000 27 2582 2589 11093437
25. The relationship between disease activity, joint destruction, and functional capacity over the course of rheumatoid arthritis. Welsing PM, van Gestel AM, Swinkels HL, Kiemeney LA, van Riel PL, Arthritis Rheum 2001 44 2009 2017 10.1002/1529-0131(200109)44:9<2009::AID-ART349>3.0.CO;2-L 11592361 (Pubitemid 33644042)